Skip to main content
OpenTrials
Completed

NCT Number: NCT05770154

Isokinetic Strength and Balance Assessment in Diabetic Patients

Diabetic polyneuropathy (DPN) is a type of nerve damage that can occur in diabetics. It can cause weakness and a loss of sensation, particularly in the legs and feet. This can have an impact on muscle strength and balance, making walking more difficult and increasing the risk of falling. Evaluating ankle muscular strength and balance using quantitative and standardised tools is critical for patients with and without DPN as well as determining how much DPN affects ankle muscle strength and balance.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Diabetic Peripheral Neuropathy (DPN) can affect ankle muscle strength and increase the risk of falling. This occurs due to nerve damage that impairs muscle function and reduces sensitivity in the feet, leading to difficulty maintaining balance and coordination. Risk factors for DPN-related falls include poor glycemic control, the duration of diabetes, age, and other comorbidities such as peripheral vascular disease. It is important for individuals with diabetes to regularly monitor and manage their DPN to prevent falls and maintain overall health. So, conducting this study to measure ankle muscle strength through isokinetic testing and dynamic balance through the Biodex balance system will help researchers quantify the extent of DPN's impact on these aspects. This study can provide a valuable predictor and assessment tool for determining the severity of neuropathy in diabetic patients. The results of this study could also help identify those at a higher risk for falls and diabetic foot complications. This information can aid healthcare providers in developing tailored interventions to improve muscle strength and balance and reduce the risk of falls in individuals with diabetes and DPN.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged from 40 to 55 years for both gender.
  • Patients with diabetes for more than 5 years.
  • Diabetic polyneuropathy was diagnosed by a neurologist.
  • Their BMI from 18 to 24.9 kg/m2.
  • The study population must be willing to participate in the study.

Exclusion criteria

  • Patients with marked deformities of the lower limbs, foot ulcers and Charcot foot.
  • .Patients with any other neurological or orthopedic diseases that may affect balance.
  • Patients with marked weakness or drop foot.
  • Patients with amputation, mental deficits, liver or renal diseases.
  • patients who had a previous surgical history (within 6 months) were also excluded prior to the baseline assessment

Treatment and study plan

Primary outcomes

  1. Peak torque

    Time frame: Through study completion, an average of 6 months.

    Isokinetic dynamometer will be used for measuring ankle dorsi and planter flexors peak torque at different angular velocities.

Secondary outcomes

  1. Power

    Time frame: Through study completion, an average of 6 months.

    Isokinetic dynamometer will be used for measuring ankle dorsi and planter flexors power at different angular velocities.

  2. Work

    Time frame: Through study completion, an average of 6 months.

    Isokinetic dynamometer will be used for measuring ankle dorsi and planter flexors work at different angular velocities

  3. Dynamic balance

    Time frame: Through study completion, an average of 6 months.

    Biodex balance system will be used to assess dynamic balance.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Ankle Isokinetic Strength and Balance Assessment in Diabetic Patients With and Without Peripheral Neuropathy at Different Angular Velocities

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Mar 15, 2023
Registry last updated
Feb 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.